Please ensure Javascript is enabled for purposes of website accessibility

Here's My Favorite Dividend Stock to Buy Right Now

By Keith Speights – Aug 22, 2021 at 5:52AM

Key Points

  • This company has quadrupled its dividend payout over the last three years.
  • It's in a great position to deliver continued growth in the future with big untapped markets.

Motley Fool Issues Rare “All In” Buy Alert

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Its dividend -- and share price -- are growing by leaps and bounds.

I'm not at the point in my life where I rely on dividends to generate income. However, quite a few stocks in my portfolio pay attractive dividends

The older I get, the more appealing dividend stocks are. I see the opportunity for dividends to provide a key source of income as I transition into retirement in the future. 

But dividend stocks aren't just for retirees. Even younger investors can reinvest dividends to obtain market-beating returns -- with the right stocks. There are plenty of alternatives that provide great dividends and strong growth potential. Here's my favorite dividend stock to buy right now.

Hand drawing upward arrow from the word "dividends."

Image source: Getty Images.

A dividend lover's dream

Innovative Industrial Properties (IIPR 2.18%) is a dividend lover's dream for several reasons. For one thing, the company has to pay a dividend as long as it's profitable. IIP is organized as a real estate investment trust (REIT). All REITs must return at least 90% of their taxable income to shareholders as dividends.

At first glance, you might not think IIP's dividend yield of 2.45% seems all that impressive. There are more than 1,700 stocks trading on major U.S. stock exchanges that offer higher yields. 

Let me put IIP's dividend yield in context, though. If you invested in the stock just three years ago and held onto your shares, your effective dividend yield today would top 15%. Why? IIP has quadrupled its dividend payout during that period.

The company was able to boost its dividend so much because its earnings skyrocketed. IIP isn't your run-of-the-mill kind of REIT. It focuses on the fast-growing U.S. medical cannabis market. 

IIP's dividend yield has declined since early 2020 solely because its share price has risen. The stock has nearly doubled over the last 12 months and is up close to 25% so far this year.

More growth to come

I think that more growth for IIP is likely on the way. The company currently owns 74 properties in 18 states. The medical cannabis markets in several of those states still have significant room to expand.

There are another 18 states that have legalized medical cannabis where IIP doesn't operate. Although most of those states don't have huge markets, they nonetheless present growth opportunities for IIP.

So far, IIP has focused only on real estate transactions with medical cannabis operators. However, the company could potentially broaden its market by targeting adult-use recreational cannabis properties as well.

Several of IIP's top customers are major multi-state operators (MSOs) that produce cannabis for both medical and recreational purposes. Publicly traded MSOs in this group such as Cresco Labs and Curaleaf could find the alternative of raising capital through selling their properties to IIP, then leasing them back, especially attractive. Sale-leaseback transactions don't require dilutive stock offerings or taking on additional debt.

Two potential risks

Every stock has its potential risks. IIP is no exception. There are two risks for the stock that especially stand out, in my view.

First, IIP appears to be priced for perfection. Its shares currently trade at 47 times expected earnings. I think a premium valuation is warranted for the stock because of its great growth prospects. However, the stock would likely sink if IIP stumbles along the way.

Second, there's a possibility that federal cannabis reform could negatively affect IIP. How? Right now, cannabis companies have limited access to traditional banking services. That makes the real estate capital option that IIP provides more appealing.

If banking services were more readily available to cannabis businesses, IIP could be forced to offer more competitive terms that reduce its earnings growth. Other REITs could also decide to enter the cannabis space if marijuana were no longer illegal at the federal level.

I think that the overall effect of federal cannabis reform would be a net positive for IIP, though. The U.S. cannabis market would probably expand even faster than it is now, creating additional opportunities for IIP despite the likelihood of increased competition.

My prediction is that IIP will continue to deliver strong growth -- and great dividends -- for years to come.

Keith Speights owns shares of Innovative Industrial Properties. The Motley Fool owns shares of and recommends Cresco Labs Inc. and Innovative Industrial Properties. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Innovative Industrial Properties Stock Quote
Innovative Industrial Properties
IIPR
$117.85 (2.18%) $2.51
Curaleaf Holdings, Inc. Stock Quote
Curaleaf Holdings, Inc.
CURLF
$6.64 (-0.41%) $0.03
Cresco Labs Inc. Stock Quote
Cresco Labs Inc.
CRLBF
$3.27 (-1.80%) $0.06

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
351%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/30/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.